While the pathophysiological role of NADPH oxidase in PCOS remains underexplored, existing evidence links hyperandrogenemia to NOX subunit p47phox upregulation in leukocytes [50], and NOX2 inhibition mitigates ROS overproduction in PCOS ovarian GCs [51]. Here, FMO5 is linked to polycystic ovary syndrome.